Probiotic in Treatment of Adult Patients With Drug-resistant Epilepsy
Status:
Completed
Trial end date:
2021-10-30
Target enrollment:
Participant gender:
Summary
This study is a randomized, double-blind parallel group placebo-controlled clinical trial
with the aim of investigating the effect of probiotic versus placebo on drug-resistant adult
patients with epilepsy.